Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
暂无分享,去创建一个
G. Klintmalm | R. Wiesner | R. Stratta | J. Lake | T. Gonwa | B. Shaw | R. Krom | N. Ascher | J. Roberts | R. Goldstein